Bio Break Book Club: Sleep Science and Change Management
In this Bio Break episode, Nick Allan and Nigel Syrotuck share what they have been reading lately. From exploring the science of sleep to diving into change management, their picks show how books can spark insight both inside and outside the lab.
Why We Sleep: A Scientific Perspective
Nick admits he has been working through Why We Sleep by Dr. Matthew Walker. The book takes a detailed look at sleep science, including melatonin levels and REM cycles. While Nick appreciates the depth and the references, he jokes that reading it at bedtime makes it hard to get very far. Despite the challenge, he calls it a fascinating resource for anyone curious about the mechanics of rest.
Change Management and Innovation
Nigel has been reading a book on change management. He explains that it helps him stay on top of how innovation is rolled out in real-world organizations. The focus is on aligning teams, improving processes, and making sure new approaches are adopted effectively. While less technical than Nick’s choice, Nigel values it as an important lens for understanding how change succeeds.
A Lighter Take on Reading
The conversation even touches on whether fish sleep, sparked by Nigel’s son asking about their new betta fish. This lighthearted exchange highlights the mix of curiosity and humor that defines the Bio Break book club. Together, Nick and Nigel show that scientific detail and organizational strategy both have a place in shaping how we think about innovation.
Enjoying Bio Break? Sign up to get new episodes sent to your inbox.
Related Resources
Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.
Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.
Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.
In this Bio Break episode, Nick and Nigel explore why some GLP-1 drugs are taken daily while others last a full week, and what drives that difference at a molecular level.